LDV Capital led the pre-seed round, with backing from Bek Ventures and Tiny Supercomputer Investment Company, to fund platform expansion and hospital deployments.
"The Royal Orthopaedic Hospital is known as one of the UK’s leading institutions in terms of outcomes and efficiency and, naturally, they have decided to utilize our platform and leverage the cutting-edge AI technology to even further increase the efficiency of surgical procedures. By autonomously tracking surgical processes and tools, VitVio minimizes the potential for human error and adds no extra steps to the surgical process, aligning with industry experts’ consensus on the importance of non-intrusive technology."
The Dublin-based artificial intelligence startup secured backing from Molten Ventures, ACT Venture Capital, and Seroba to expand its global footprint.
"This investment accelerates our mission to transform global pathology access. Our ergonomic, AI-enabled platform enhances diagnostic workflow and accuracy – allowing experts to clear backlogs faster without compromising quality. By expanding this technology worldwide, we’re not just improving healthcare efficiency, we’re supporting both the pathologists who drive diagnoses and the patients who depend on them."
The financing round was led by.406 Ventures to support team growth and international expansion.
"Mindgard’s innovative approach, born out of the distinct challenges of securing AI, equips security teams and developers with the tools they need to deliver secure AI systems. Mindgard is well-positioned to lead this emerging market and we are thrilled to partner with them on this journey."
The funding round was backed by the Development Bank of Wales and SFC Capital.
"We want to improve the user experience so that using this technology feels as intuitive as using a smartphone. Pretty much everyone has a smartphone these days and the technology underpinning them is very sophisticated, but the end user in most cases does not need to know how that all works – it just works. PurifAI is about putting cutting-edge testing power directly into the hands of users, wherever they are and whatever their DNA question may be."
.png)